Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.05 USD | +0.69% | +7.61% | -4.05% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Biopharmaceuticals | +1.13% | +7.61% | -4.05% | +22.75% | +410.44% | 1.88B |
Technical Rankings Surperformance
- Stock Market
- Equities
- CPRX Stock
- Charts Catalyst Pharmaceuticals, Inc.
- Comparison Chart